Metabolite List

all metabolites that has the same formula 'C7H8N4O3'

1,7-Dimethyluric acid (BioCAD00000001697)
Formula: C7H8N4O3 (Exact Mass: 196.0596)

1,7-Dimethyluric acid is the major urinary caffeine metabolite that is produced in the human body. 1,7-Dimethyluric acid is formed during caffeine metabolism and the process is catalyzed primarily by CYP2A6 (PMID: 18715882).

blood feces urine kidney liver plant natural products
3,7-Dimethyluric acid (BioCAD00000003975)
Formula: C7H8N4O3 (Exact Mass: 196.0596)

3,7-Dimethyluric acid is a methyl derivative of uric acid, found occasionally in human urine. 3,7-Dimethyluric is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis (PMID:11712316, 15833286, 3506820, 15013152).

blood feces urine kidney liver
1,3-Dimethyluric acid (BioCAD00000019978)
Formula: C7H8N4O3 (Exact Mass: 196.0596)

1,3-Dimethyluric acid is a product of theophylline metabolism in man. 1,3-Dimethyluric acid is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID:11712316, 15833286, 3506820, 15013152, 4039734).

blood feces urine kidney liver
1,9-Dimethyluric acid (BioCAD00000020034)
Formula: C7H8N4O3 (Exact Mass: 196.0596)

1,9-Dimethyluric acid is a methyl derivative of uric acid, found occasionally in human urine. 1,9-Methyluracil is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID:11712316, 15833286, 3506820, 15013152).

blood urine kidney liver
7,9-Dimethyluric acid (BioCAD00000020331)
Formula: C7H8N4O3 (Exact Mass: 196.0596)

7,9-Dimethyluric acid is a methyl derivative of uric acid, found occasionally in human urine. 7,9-Dimethyluracil is one of the purine component in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. (PMID: 11712316, 15833286, 3506820).

blood urine kidney liver
3,9-Dimethyluric acid (BioCAD00000055214)
Formula: C7H8N4O3 (Exact Mass: 196.0596)

3,9-Dimethyluric acid is involved in purine oxidation pathways. Reevaluation of products derived from 3,9-dimethyluric acid in a chlorination-reductive dechlorinaton sequence has demonstrated unequivocally that they are not purines.(PMID 14601976)

urine
Dimethyluric acid (BioCAD00000375262)
Formula: C7H8N4O3 (Exact Mass: 196.0596)

1,3-Dimethyluric acid; LC-tDDA; CE40 (BioCAD00000776738)
Formula: C7H8N4O3 (Exact Mass: 196.0596)

1,3-Dimethyluric acid; LC-tDDA; CE30 (BioCAD00000776739)
Formula: C7H8N4O3 (Exact Mass: 196.0596)

1,3-Dimethyluric acid; LC-tDDA; CE20 (BioCAD00000776740)
Formula: C7H8N4O3 (Exact Mass: 196.0596)

1,3-Dimethyluric acid; LC-tDDA; CE10 (BioCAD00000776741)
Formula: C7H8N4O3 (Exact Mass: 196.0596)

1,3-Dimethyluric acid; AIF: CE30; MS2Dec (BioCAD00000777890)
Formula: C7H8N4O3 (Exact Mass: 196.0596)

1,3-Dimethyluric acid; AIF: CE10; MS2Dec (BioCAD00000777891)
Formula: C7H8N4O3 (Exact Mass: 196.0596)

1,3-Dimethyluric acid; AIF: CE0; MS2Dec (BioCAD00000777892)
Formula: C7H8N4O3 (Exact Mass: 196.0596)

1,3-Dimethyluric acid; AIF: CE30; CorrDec (BioCAD00000777893)
Formula: C7H8N4O3 (Exact Mass: 196.0596)

1,3-Dimethyluric acid; AIF: CE10; CorrDec (BioCAD00000777894)
Formula: C7H8N4O3 (Exact Mass: 196.0596)

1,3-Dimethyluric acid; AIF: CE0; CorrDec (BioCAD00000777895)
Formula: C7H8N4O3 (Exact Mass: 196.0596)

1,7-Dimethyluric acid; AIF; CE30; MS2Dec (BioCAD00000778050)
Formula: C7H8N4O3 (Exact Mass: 196.0596)

1,7-Dimethyluric acid; AIF; CE10; MS2Dec (BioCAD00000778051)
Formula: C7H8N4O3 (Exact Mass: 196.0596)

1,7-Dimethyluric acid; AIF; CE0; MS2Dec (BioCAD00000778052)
Formula: C7H8N4O3 (Exact Mass: 196.0596)